CClinicalTrials.gg
Status unknownNCT04276285Updated Aug 20, 2020

Laparoscopic Versus US-Guided Subcostal TAP Block After Laparoscopic Cholecystectomy

An interventional study of Laparoscopic TAP and US TAP in Cholecystitis; Gallstone, sponsored by Mansoura University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-08-20.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Zaghiyan et al hypothesized that Laparoscopic TAP was noninferior to US-TAP and performed a randomized clinical trial comparing Laparoscopic TAP, US-TAP, and no TAP in minimally invasive colorectal surgery. The authors reported that LTAP was superior to UTAP in achieving pain control and minimizing opioid use in the first 24 hours after colorectal surgery.

This prospective randomized, controlled trial will be performed to assessed the efficacy of laparoscopic subcostal TAP block (LSTAP) compared to ultrasound-guided subcostal TAP (USTAP) block after laparoscopic cholecystectomy regarding postoperative pain scores in the first 24-hours after the intervention and analgesic requirements.

02

Conditions studied

  • Cholecystitis; Gallstone
03

In context

Cholecystitis

266 studies on the registry are indexed under Cholecystitis; 46 are open to participants now.

This study's planned enrollment of 94 is close to the median of 86 across 167 interventional studies indexed under Cholecystitis.

Browse Cholecystitis studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Consecutive adult patients of either gender who will undergo laparoscopic cholecystectomy will be recruited to the study.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • Patients who will undergo open cholecystectomy
  • Patients who will need conversion to conventional open cholecystectomy
  • Patients with ASA III classification or higher
  • Patients who will undergo laparoscopic cholecystectomy together with other abdominal interventions.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
94 participants (estimated)

Study arms

  • Active comparator
    Laparoscopic TAP

    Subcostal TAP block will be performed after surgery under laparoscopic guidance

    Procedure: Laparoscopic TAP

  • Active comparator
    US TAP

    Subcostal TAP block will be performed after surgery under ultrasound guidance

    Procedure: US TAP

  • No intervention
    No TAP

    No TAP block will be performed

Interventions

  • ProcedureLaparoscopic TAP

    Subcostal TAP block will be performed after surgery under laparoscopic guidance

  • ProcedureUS TAP

    Subcostal TAP block will be performed after surgery under US guidance

06

What researchers measure

Primary outcomes

  1. Pain score

    pain will be assessed with visual analogue scale from 0-10

    Time frame: 24 hours after cholecystectomy

Secondary outcomes

  1. Analgesic requirement

    the need for intravenous analgesia after surgery calculated as the cumulative dose of analgesic administered over 24 hours

    Time frame: 24 hours after cholecystectomy

07

Study locations

1 of 1 sites recruiting
  • Mansoura university hospital
    Mansourah, Dakahlia 35516, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04276285
Lead sponsor
Mansoura University
Responsible party
Sameh Emile (lecturer of surgery, Mansoura University) — Principal investigator
First posted
Feb 19, 2020
Start date
Feb 17, 2020
Primary completion
Feb 28, 2021 (estimated)
Completion
Mar 30, 2021 (estimated)
Last update
Aug 20, 2020

Study contacts

Sameh H Emile, M.D.
Contact
sameh200@hotmail.com
+201006267150
Sameh H Emile, M.D.
principal investigator · Mansoura University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion